Olr434 Activators
Chemical activators of Olr434 engage in a series of interactions that lead to the protein's activation through a common signaling pathway involving the cyclic AMP (cAMP) molecule and protein kinase A (PKA). Epinephrine, isoproterenol, and terbutaline are all catecholamines or catecholamine analogs that bind to beta-adrenergic receptors. Upon binding, these receptors, which are G protein-coupled receptors (GPCRs), activate adenylyl cyclase, an enzyme that catalyzes the conversion of ATP to cAMP. The increase in cAMP levels, in turn, leads to the activation of PKA. Once PKA is activated, it can phosphorylate various substrates, including Olr434, thereby activating the protein. Similarly, prostaglandin E2 (PGE2) and glucagon also bind to their respective GPCRs, stimulating adenylyl cyclase and leading to the same cascade of events culminating in Olr434 activation.
Forskolin bypasses receptor-mediated stimulation and directly activates adenylyl cyclase, leading to a rise in cAMP and subsequent PKA activation, which then phosphorylates and activates Olr434. Other compounds, such as IBMX, caffeine, zaprinast, and vardenafil, achieve their effects by inhibiting phosphodiesterases, the enzymes responsible for degrading cAMP. The inhibition of cAMP breakdown results in an accumulation of the molecule within the cell, which sustains PKA activation and the phosphorylation of Olr434. Histamine and adenosine, on the other hand, bind to their H2 and A2 receptors respectively, both of which are coupled to Gs proteins that stimulate adenylyl cyclase, again resulting in increased cAMP, PKA activation, and Olr434 phosphorylation. These various chemicals, despite their different targets and mechanisms of action, all converge on a shared pathway that leads to the elevation of cAMP levels and the activation of PKA, ultimately resulting in the activation of Olr434.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine engages with beta-adrenergic receptors which are G protein-coupled receptors (GPCRs). Activation of these GPCRs can lead to downstream activation of adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP can activate PKA, which can phosphorylate and thus activate Olr434, assuming Olr434 is a protein that is regulated by phosphorylation through PKA. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, a synthetic catecholamine and beta-adrenergic agonist, binds to and activates beta-adrenergic receptors, triggering a similar cAMP-PKA signaling cascade as epinephrine. This activation can lead to the phosphorylation and activation of Olr434. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, which normally break down cAMP. By preventing cAMP degradation, IBMX indirectly increases PKA activity, which can phosphorylate and activate Olr434. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) binds to its G protein-coupled EP receptors, which can activate adenylyl cyclase and increase cAMP levels, leading to PKA activation and the downstream phosphorylation and activation of Olr434. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can bind to G protein-coupled histamine H2 receptors, which activate adenylyl cyclase, increase cAMP levels, and subsequently activate PKA. PKA can then phosphorylate and activate Olr434. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine is a competitive inhibitor of phosphodiesterases that degrade cAMP. By maintaining higher levels of cAMP, caffeine indirectly increases PKA activity, which could lead to the phosphorylation and activation of Olr434. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine interacts with A2 adenosine receptors, which are coupled to Gs proteins that activate adenylyl cyclase, increasing cAMP and activating PKA. PKA may phosphorylate and activate Olr434. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $92.00 $378.00 | 2 | |
Terbutaline is a beta2-adrenergic agonist that activates adenylyl cyclase via the beta2-adrenergic receptor, increasing cAMP and activating PKA, which can phosphorylate and activate Olr434. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterase 5, leading to an increase in cAMP levels, which can enhance PKA activity. PKA, in turn, can phosphorylate and activate Olr434. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
Vardenafil, a phosphodiesterase 5 inhibitor, prevents the breakdown of cGMP, which can have a secondary effect on cAMP levels. This can lead to increased PKA activity, potentially phosphorylating and activating Olr434. | ||||||